Cape Verde vs Guinea: Access to anti-retroviral drugs, male
Cape Verde
64.0%
in 2024
Guinea
64.0%
in 2024
Cape Verde rank
87th
Guinea rank
87th
Access to anti-retroviral drugs, male over time
- Cape Verde
- Guinea
How they compare
Cape Verde currently reports 64.0% against 64.0% in Guinea, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Guinea ahead.
Cape Verde ranks 87th and Guinea ranks 87th of 141 countries.
Cape Verde has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cape Verde | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.0% | 4.6% | 5.4% | Cape Verde |
| 2010s | 43.6% | 26.9% | 16.7% | Cape Verde |
| 2020s | 61.8% | 51.2% | 10.6% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cape Verde or Guinea?
- Cape Verde, at 64.0% against 64.0% in Guinea as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cape Verde and Guinea?
- 0.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Guinea?
- 25 years are reported by both, from 2000 to 2024.
- How do Cape Verde and Guinea rank globally for access to anti-retroviral drugs, male?
- Cape Verde ranks 87th and Guinea ranks 87th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.